obsolete_common variable immunodeficiency: ['A hypogammaglobulinemia that is results in insufficient production of antibodies needed to respond to exposure of pathogens and is characterized by low Ig levels with phenotypically normal B cells that can proliferate but do not develop into Ig-producing cells. Patients with common variable immunodeficiency have marked reduction in serum levels of both immunoglobulin G (IgG) and immunoglobulin A (IgA); about half of these patients also have reduced immunoglobulin M (IgM).', 'A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.', 'Heterogeneous group of immunodeficiency syndromes characterized by hypogammaglobulinemia of most isotypes, variable B-cell defects, and the presence of recurrent bacterial infections.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
221 |
6. Filter based on genotype QC (FinnGen only) |
221 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80-D89
- Name in latin
- Deficientia immunalis variabilis communis
Similar endpoints
↥List of similar endpoints to
Common variable immunodeficiency
based on the number of shared cases.
Similar with more cases:
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
- Other or unspecified common variable immunodeficiency
- Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
- Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function
- Common variable immunodeficiency with autoantibodies to B- or T-cells
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 938 | 523 | 407 |
| Only index persons | 837 | 484 | 353 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 50.88 | 51.24 | 50.30 |
| Only index persons | 49.07 | 50.37 | 47.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 221 | 140 | 81 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.04 |
| Median age at first event (years) | 48.61 | 49.70 | 46.73 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 201
- Matched controls
- 2009
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
107.1
93
*
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
99.4
87
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
98.2
86
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
89.4
79
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
85.7
76
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
28.6
44.4
61
30
D83.1
ICD-10 Finland
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
+∞
44.4
41
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
43.3
40
*
J47
ICD-10 Finland
Bronchiectasis
170.4
40.4
41
*
6BA02
NOMESCO Finland
NA
+∞
39.9
37
*
ZX120
NOMESCO Finland
Intravenous
12.8
37.5
72
84
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
35.5
33
*
D83.8
ICD-10 Finland
Other common variable immunodeficiencies
+∞
35.5
33
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
28.8
27
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
10.2
27.4
58
77
J01MA14
ATC
moxifloxacin; systemic
9.5
26.4
58
82
TDM10
NOMESCO Finland
Puncture of maxillary antrum
14.9
25.8
44
37
H02AB06
ATC
prednisolone; systemic
5.0
24.8
141
644
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.3
23.1
86
247
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
22.3
21
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
21.9
124
538
UGC12
NOMESCO Finland
Flexible bronchoscopy
9.8
21.9
46
59
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
13.5
21.6
38
34
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.0
21.3
66
150
J01MA12
ATC
levofloxacin; systemic
5.2
20.9
77
214
C01CA24
ATC
epinephrine; parenteral
9.2
20.7
45
61
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
15.5
20.6
34
26
WW200
NOMESCO Finland
Immunization
19.0
20.4
31
19
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.4
19.1
44
65
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.9
19.0
42
58
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
9.0
18.0
39
52
TPH04
NOMESCO Finland
Cathetrisation of vein
4.4
17.4
75
238
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
17.3
93
359
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.3
17.1
28
21
UDH02
NOMESCO Finland
Rhinopharyngoscopy
8.1
16.5
38
56
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.9
16.1
31
33
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.0
16.1
80
284
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
7.4
15.9
39
63
D86.0
ICD-10 Finland
Sarcoidosis of lung
+∞
15.8
15
*
J32.4
ICD-10 Finland
Chronic pansinusitis
41.6
15.7
19
5
J01FA06
ATC
roxithromycin; oral
3.4
15.0
118
598
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
+∞
14.8
14
*
Z2221
NOMESCO Finland
Medical doctor
3.6
14.6
85
341
R50.9
ICD-10 Finland
Fever, unspecified
4.4
14.2
57
165
H02AB07
ATC
prednisone; oral
4.5
14.2
55
154
TGC00
NOMESCO Finland
Bronchial lavation
20.8
13.2
19
10
GD1AD
NOMESCO Finland
Thorax CT examination
11.7
13.2
24
23
Z3231
NOMESCO Finland
Registered nurse
3.3
13.0
83
350
J01FA15
ATC
telithromycin; oral
4.8
12.9
46
117
J45.9
ICD-10 Finland
Asthma, unspecified
3.9
12.9
61
204
Z01.8
ICD-10 Finland
Other specified special examinations
3.5
12.7
71
271
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
12.6
12
*
J45.1
ICD-10 Finland
Nonallergic asthma
6.5
12.5
33
59
M05BA04
ATC
alendronic acid; oral
6.0
12.4
35
68
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
12.3
89
406
J01FF01
ATC
clindamycin; systemic
3.1
11.4
81
363
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.9
11.2
28
46
Z3226
NOMESCO Finland
Physiotherapist
3.5
11.1
59
214
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
46.0
11.1
13
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.7
10.9
38
94
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.9
10.7
48
151
SPAT1262
SPAT
Handing over of treatment supplies
3.5
10.7
56
199
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
10.5
10
*
M36.8*D80.1
ICD-10 Finland
Systemic disorders of connective tissue in hypogammaglobulinaemia
+∞
10.5
10
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
10.5
10
*
J05AB11
ATC
valaciclovir; oral
4.0
10.5
45
136
J01MA02
ATC
ciprofloxacin; systemic
2.8
10.5
99
521
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
24.9
10.4
14
6
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.7
10.3
126
773
R01AD09
ATC
mometasone; nasal
2.7
10.3
116
679
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.1
10.3
28
52
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.2
10.1
61
240
J45.8
ICD-10 Finland
Mixed asthma
9.5
10.0
20
23
R01AD05
ATC
budesonide; nasal
5.1
9.8
31
69
A07AA02
ATC
nystatin; oral
5.7
9.5
27
53
B99
ICD-10 Finland
Other and unspecified infectious diseases
23.0
9.5
13
6
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
9.4
9
*
132
Kela drug reimbursment
Sarcoidosis
+∞
9.4
9
*
J02AC01
ATC
fluconazole; systemic
2.6
9.3
101
564
UJF30
NOMESCO Finland
Ileoscopy through colon
4.2
9.2
36
100
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.3
9.1
50
183
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.5
9.0
111
663
H02AB09
ATC
hydrocortisone; systemic
11.5
9.0
16
15
H02AB04
ATC
methylprednisolone; systemic
3.4
8.9
46
161
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.7
8.9
75
362
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
8.9
32
82
A07EA06
ATC
budesonide; oral, local oral
8.9
8.8
18
22
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
10.7
8.7
16
16
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
7.9
8.7
19
26
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
17.2
8.7
13
8
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
7.3
8.6
20
30
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
8.5
86
459
ZXA00
NOMESCO Finland
Right side
2.8
8.5
66
301
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
6.6
8.4
21
35
R03DA04
ATC
theophylline; systemic, rectal
6.6
8.4
21
35
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
+∞
8.4
8
*
D83.2
ICD-10 Finland
Common variable immunodeficiency with autoantibodies to B- or T-cells
+∞
8.4
8
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
+∞
8.4
8
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.0
8.3
34
98
UJF32
NOMESCO Finland
Coloscopy
2.7
8.3
64
292
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
8.7
8.3
17
21
R4110
NOMESCO Finland
Physiotherapy
2.7
8.3
65
298
R03BB04
ATC
tiotropium bromide; inhalant
4.3
8.1
30
79
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.0
7.9
17
23
J01FA09
ATC
clarithromycin; systemic
2.5
7.8
80
424
R03AC12
ATC
salmeterol; inhalant
6.6
7.8
19
31
J46
ICD-10 Finland
Status asthmaticus
8.6
7.8
16
20
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
19.3
7.7
11
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
7.7
65
312
R03DC03
ATC
montelukast; oral
3.0
7.7
49
197
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
26.1
7.6
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
7.6
90
512
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
7.6
29
79
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
7.6
41
147
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.3
7.5
39
137
J01DA01
ATC
[U] cefalexin; systemic
2.3
7.5
137
959
D73.1
ICD-10 Finland
Hypersplenism
+∞
7.3
7
*
N02AX02
ATC
tramadol; systemic, rectal
2.3
7.3
93
545
UJF92
NOMESCO Finland
Capsular endoscopy
8.4
7.2
15
19
1XC02
NOMESCO Finland
NA
31.2
7.2
9
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
20.9
7.2
10
5
J01DA06
ATC
[U] cefuroxime; systemic
3.0
7.2
44
173
P01AB01
ATC
metronidazole; oral, rectal
2.3
7.1
92
542
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
7.1
37
130
J01DA08
ATC
[U] cefaclor; oral
3.3
7.1
37
130
R03BA02
ATC
budesonide; inhalant
2.7
7.1
52
227
C03CA01
ATC
furosemide; systemic
2.6
7.1
57
264
XW000
NOMESCO Finland
Bone marrow biopsy
7.1
7.0
16
24
K90.0
ICD-10 Finland
Coeliac disease
8.8
6.9
14
17
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
6.9
43
170
J32.8
ICD-10 Finland
Other chronic sinusitis
41.5
6.8
8
*
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
41.5
6.8
8
*
R03AC02
ATC
salbutamol; inhalant
2.2
6.7
120
812
A02BC01
ATC
omeprazole; systemic
2.4
6.6
66
341
ZXE00
NOMESCO Finland
One hour or less
2.2
6.5
90
541
R05
ICD-10 Finland
Cough
2.6
6.5
51
230
E83.1
ICD-10 Finland
Disorders of iron metabolism
72.0
6.5
7
*
B99
ICPC
Blood/lymph/spleen disease other
72.0
6.5
7
*
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
72.0
6.5
7
*
GD1CG
NOMESCO Finland
Extensive examination of lungs and pleura with high intensity magnet
72.0
6.5
7
*
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.7
6.5
27
80
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
6.5
41
165
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.8
6.4
26
75
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
18.7
6.3
9
5
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
6.3
6
*
D81.0
ICD-10 Finland
Severe combined immunodeficiency [SCID] with reticular dysgenesis
+∞
6.3
6
*
D80.6
ICD-10 Finland
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
+∞
6.3
6
*
TPH00
NOMESCO Finland
Phlebotomy
+∞
6.3
6
*
B29
ICPC
Lymph/immune mech sympt/complt other
27.6
6.3
8
*
Z31.5
ICD-10 Finland
Genetic counselling
4.3
6.2
22
56
A05AA02
ATC
ursodeoxycholic acid; oral
13.1
6.1
10
8
J01AA02
ATC
doxycycline; systemic
2.4
6.0
164
1306
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3028026) IgM [Mass/volume] in Serum or Plasma
128
114
25.31
135.70
5.0
1.7
g/l
0.9
1.5
0.84
104
109
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
71
12
86.70
131.39
2.1
1.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
72
14
75.80
129.93
2.1
1.4
%
10.8
8.1
—
49
8
(3011412) CD3 cells [#/volume] in Blood
76
21
54.64
126.93
2.2
1.2
e9/l
1.1
1.1
—
61
7
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
58
17
45.90
94.27
2.3
1.1
e9/l
0.2
0.2
0.04
48
12
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
57
17
44.84
92.13
2.3
1.1
e6/l
451.8
833.3
0.91
47
12
(4062490)
46
13
44.42
74.89
1.8
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
69
7
142.06
67.47
6.0
1.0
u/ml
774.1
1024.7
—
69
7
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
59
5
159.90
58.11
2.9
1.2
u/l
16.1
12.8
—
59
5
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
40
18
26.91
55.67
1.8
1.4
e6/l
917.0
798.7
—
5
9
(3006245) CD3-CD19+ cells/100 cells in Blood
53
9
76.82
47.87
2.2
1.6
%
8.6
5.8
—
48
9
(3007164) IgA [Mass/volume] in Serum or Plasma
137
412
7.12
47.62
5.1
1.4
g/l
1.2
2.3
11.00
85
264
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
42
12.83
41.56
1.7
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
155
586
6.51
39.95
17.4
5.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
66
113
7.90
39.62
2.2
1.2
u/ml
100.4
323.8
0.52
42
101
(3001604) Monocytes [#/volume] in Blood
185
897
7.52
33.66
21.9
5.6
e9/l
0.5
0.6
0.78
177
792
(3006315) Basophils [#/volume] in Blood
185
899
7.49
33.51
22.1
5.6
e9/l
0.0
0.0
1.30
178
796
(3019198) Lymphocytes [#/volume] in Blood
186
927
7.36
32.13
22.0
5.7
e9/l
1.7
2.0
0.80
179
839
(3013115) Eosinophils [#/volume] in Blood
186
930
7.31
31.92
22.2
6.1
e9/l
0.2
0.2
0.46
179
835
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
39
47
9.86
30.99
3.0
3.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
24
13
20.59
30.40
2.1
1.2
e9/l
1.0
0.2
0.43
24
13
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
58
118
6.31
28.87
2.4
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
29
25
13.20
28.85
4.8
3.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
25
0
+∞
26.59
1.3
0.0
ug/g
169.2
—
—
19
0
(3023368) Bacteria identified in Blood by Culture
107
390
4.38
26.12
6.5
4.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
185
1056
5.62
23.33
25.4
9.4
e9/l
3.5
4.0
3.05
177
934
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
79
248
4.40
23.19
2.8
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
40
8.85
23.15
1.7
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
70
203
4.58
22.75
4.8
2.4
%
20.5
22.4
0.54
63
175
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
30
38
8.98
22.72
1.7
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
74
231
4.31
21.73
3.2
2.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
20
0
+∞
21.18
1.7
0.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
39
72
6.36
21.10
2.8
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
172
4.52
20.36
2.4
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
74
246
4.02
19.72
2.9
2.5
ug/g
125.2
122.4
0.03
64
195
(3024561) Albumin [Mass/volume] in Serum or Plasma
141
718
3.66
19.49
9.4
4.5
g/l
34.3
36.1
2.93
136
671
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
28
9.49
19.26
1.5
1.6
—
—
—
0
0
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
3.4
—
—
10
0
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
0.7
—
—
10
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
0.4
—
—
11
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
0.6
—
—
10
0
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
1.5
—
—
11
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
1.8
—
—
9
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
3.6
—
—
11
0
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
0.5
—
—
11
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
1.5
—
—
12
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
18
0
+∞
19.03
2.2
0.0
mg/l
0.7
—
—
8
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
21
10.95
18.77
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
61
185
4.17
18.34
4.0
1.4
—
—
—
0
0
(44790048)
18
15
12.98
18.02
1.7
1.6
—
—
—
0
0
(44790049)
18
15
12.98
18.02
1.7
1.6
—
—
—
0
0
(44790047)
18
15
12.98
18.02
1.7
1.6
—
—
—
0
0
(44806118)
18
15
12.98
18.02
1.7
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
57
6.40
17.84
1.4
2.5
g/l
1.3
1.4
0.18
27
49
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
95
395
3.46
17.81
4.0
2.0
mg/l
3.0
3.3
0.73
89
350
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
176
4.11
17.35
2.6
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
101
442
3.37
17.33
16.5
6.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
32
8.29
17.32
1.5
1.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
16
0
+∞
16.88
2.0
0.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
48
130
4.44
16.65
10.6
4.0
%
0.5
0.3
0.55
16
34
(3023520) Reticulocytes [#/volume] in Blood
43
108
4.70
16.39
4.6
2.9
e9/l
77.8
73.8
0.26
34
80
(21494814) CD8 cells/100 lymphocytes in Specimen
20
6
36.41
16.03
1.9
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
20
6
36.41
16.03
1.9
1.5
%
12.3
7.0
—
20
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
18
10.80
16.02
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
220
3.69
15.90
1.8
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
21
9.80
15.78
1.7
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
115
575
3.08
15.27
5.2
3.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
17
10.75
15.10
2.5
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
17
10.75
15.10
2.5
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
21
28
8.18
15.10
1.8
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
39
97
4.67
14.99
1.8
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
195
1344
4.83
14.87
13.2
3.9
mm/h
12.2
10.5
0.80
190
1242
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
20
9.71
14.86
1.4
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
142
807
3.12
14.86
10.6
7.1
mmol/l
1.2
1.2
1.03
127
676
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
132
723
3.05
14.71
4.7
2.4
nmol/l
77.6
75.7
0.35
125
653
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
18
5
38.95
14.68
1.2
1.0
%
82.1
102.6
—
18
5
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
18
5
38.95
14.68
1.2
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
96
445
3.05
14.40
4.6
3.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
14
11
13.52
14.39
1.0
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
79
328
3.19
14.35
4.1
2.6
mosm/kgh2o
531.5
548.5
0.27
71
276
(3017181) Myelocytes/100 leukocytes in Blood
48
146
3.92
14.12
11.7
4.2
%
0.6
0.6
0.07
16
49
(3021589) Normoblasts [#/volume] in Blood
141
814
3.02
14.05
26.4
8.9
e9/l
0.0
0.0
0.51
132
671
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
132
738
2.96
13.91
8.5
6.4
mmol/l
1.2
1.2
2.00
127
673
(3007853) Bacteria identified in Skin by Aerobe culture
60
215
3.46
13.81
2.8
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
21
32
7.15
13.45
10.6
3.2
%
52.0
55.1
0.30
21
32
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
20
9.13
13.43
1.4
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
15
10.66
13.27
2.6
1.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
94
449
2.90
13.12
4.8
3.1
e6/l
0.4
0.4
0.05
78
337
(3032080) INR in Blood by Coagulation assay
116
620
2.83
13.07
10.2
6.9
inr
1.0
1.2
2.37
28
193
(3030905) Polymorphonuclear cells [#/volume] in Blood
20
30
7.23
12.98
10.4
3.1
e9/l
3.5
4.4
0.78
20
30
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
24
8.08
12.89
1.5
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
44
136
3.79
12.58
12.5
4.3
%
0.0
0.0
0.80
16
44
(3015171) Extractable nuclear Ab [Units/volume] in Serum
29
65
4.98
12.55
1.2
1.3
—
3.9
—
0
7
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
50
5.51
12.27
1.4
1.3
ug/g
399.5
325.2
1.15
20
23
(3052851) Hemolysis interference index of Serum or Plasma
26
54
5.32
12.25
3.1
3.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
78
348
2.92
12.21
4.1
2.5
e6/l
5.3
5.2
0.01
73
306
(3018418) pH of Serum or Plasma
99
501
2.77
12.20
5.1
3.7
ph
7.4
7.4
0.40
19
85
(3037522) Nuclear Ab [Titer] in Serum
63
254
3.07
11.77
1.8
1.4
titre
160.0
526.8
1.99
11
53
(3002582) Erythrocytes [#/volume] in Urine
98
503
2.70
11.62
4.7
3.2
e6/l
27.9
168.4
0.56
82
384
(3002032) Base excess in Venous blood by calculation
41
129
3.67
11.37
3.8
4.7
mmol/l
1.7
2.0
0.25
36
101
(3018095) Leukocytes [#/volume] in Urine
109
595
2.64
11.35
5.4
3.8
e6/l
242.5
133.9
0.21
85
413
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
16
9.27
11.24
2.8
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
88
437
2.68
11.04
16.0
4.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
36
6.01
10.91
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
41
135
3.50
10.59
12.9
4.2
%
0.0
0.2
0.57
15
38
(3042631) Mycobacterium sp identified in Specimen
14
18
8.24
10.26
3.4
4.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
18
8.24
10.26
1.6
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
13
9.70
9.96
1.2
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
29
6.27
9.75
1.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
14
9.01
9.43
4.7
3.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
56
241
2.77
9.08
1.4
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
24
60
4.37
9.05
4.5
3.9
g/l
0.1
0.4
0.73
15
26
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
40
5.10
8.77
1.7
2.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
13
8.85
8.53
1.1
1.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
16
7.87
8.49
2.8
1.3
u/ml
0.7
0.1
—
7
7
(3037756) Immunofixation for Serum or Plasma
15
26
6.12
8.45
1.1
2.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
10
11
9.47
8.15
2.0
1.5
u/l
1.6
4.3
—
5
6
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
75
3.80
8.10
2.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
72
383
2.31
7.30
4.2
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
102
627
2.16
7.23
2.5
1.9
pmol/l
90.8
98.8
0.77
62
309
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
23
5.94
7.15
2.1
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
143
1007
2.19
7.09
7.1
4.7
mmol/l
6.7
6.5
0.59
137
934
(3035350) Ketones [Presence] in Urine by Test strip
128
869
2.12
6.91
5.1
3.4
estimate
0.0
0.0
0.00
33
174
(3025941) Bacteria identified in Stool by Culture
29
100
3.19
6.89
2.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
128
870
2.12
6.87
6.5
4.7
estimate
0.0
0.0
0.00
32
173
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
64
3.71
6.76
1.5
1.5
g/l
2.5
3.8
4.69
17
50
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
64
3.71
6.76
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
86
3.29
6.60
2.4
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
128
882
2.07
6.49
4.9
3.5
estimate
0.0
0.0
0.00
32
165
(3019060) Gas panel - Arterial blood
27
93
3.17
6.42
2.8
10.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
63
334
2.24
6.33
1.8
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
22
67
3.54
6.33
3.2
3.4
mmol/l
24.8
25.2
0.19
22
67
(3021960) Folate [Moles/volume] in Serum or Plasma
69
381
2.18
6.27
2.2
1.5
nmol/l
18.8
22.6
1.98
63
325
(3037467) Urinalysis macro (dipstick) panel - Urine
163
1241
2.19
6.20
7.8
4.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
31
4.75
6.07
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
31
4.75
6.07
1.6
1.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
31
120
2.84
6.02
10.7
8.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
32
4.60
5.85
1.3
2.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
9
11.56
5.85
1.2
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
71
406
2.10
5.84
2.0
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
66
3.41
5.76
1.2
2.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
51
3.75
5.73
1.6
1.4
iu/ml
0.0
0.0
—
6
8
(3044640) Blood type and Crossmatch panel - Blood
88
548
2.01
5.72
3.2
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
17
6.11
5.68
1.9
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
17
6.11
5.68
1.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
17
6.11
5.68
1.9
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
20
62
3.45
5.60
4.2
3.3
%
53.7
51.1
0.14
20
62
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
17
47
3.84
5.60
3.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
25
5.02
5.56
4.1
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
25
5.02
5.56
4.1
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
18
5.77
5.37
1.3
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
30
4.54
5.37
1.6
3.9
—
—
—
0
0
(4035726)
35
153
2.53
5.37
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
26
4.82
5.32
4.1
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
26
4.82
5.32
4.2
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
26
4.82
5.32
4.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
26
4.82
5.32
4.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
161
2.48
5.27
8.3
11.0
mmol/l
0.5
1.4
0.57
25
127
(3022145) Colonoscopy Study observation
44
218
2.27
5.12
1.5
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
6
13.76
5.12
1.5
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
6
13.76
5.12
1.5
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
6
13.76
5.12
4.5
6.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
80
504
1.92
4.89
4.1
2.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
42
3.76
4.86
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
58
3.29
4.75
1.7
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
50
269
2.11
4.74
1.9
1.7
nmol/l
1437.0
1158.9
0.87
44
208
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
68
410
1.95
4.71
3.3
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
270
2.10
4.69
3.0
2.9
e6/l
1.3
0.8
0.46
29
148
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
59
3.23
4.63
1.7
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
5
14.39
4.60
3.4
1.2
ug/l
72.6
79.8
—
7
5
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
5
14.39
4.60
1.1
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
8
10.32
4.55
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
60
3.18
4.51
3.7
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
60
3.18
4.51
1.7
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
115
830
1.80
4.46
4.6
4.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
19
66
3.06
4.45
3.0
2.9
%
2.2
1.2
1.06
19
66
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
260
2.08
4.45
3.2
3.1
e6/l
1.6
2.7
0.86
27
138
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
207
1828
3.09
4.40
40.3
12.4
mg/l
18.3
21.2
0.90
192
1401
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
9
9.17
4.31
2.3
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
62
3.07
4.28
3.3
2.1
—
—
—
0
0
(4010399)
27
117
2.49
4.21
1.7
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
13
7.16
4.20
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
66
410
1.87
4.11
3.3
2.5
ng/l
1390.2
1172.8
0.11
57
340
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
247
2.03
4.01
1.7
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
15
48
3.28
4.01
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
70
448
1.82
3.95
1.4
1.3
u/ml
2.4
1.6
0.15
13
125
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
34
3.67
3.82
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
31
150
2.24
3.80
1.6
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
5
12.28
3.78
2.5
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
25
4.14
3.74
1.2
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
14
45
3.25
3.72
1.6
3.2
mg/l
33.3
64.0
—
9
37
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
30
3.81
3.68
1.1
1.1
—
—
—
0
0
(3020891) Body temperature
15
51
3.08
3.65
4.1
5.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
26
3.98
3.56
1.2
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
6
10.23
3.51
21.7
29.3
ug/l
5.7
7.2
—
6
6
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
6
10.23
3.51
1.2
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
183
1576
1.94
3.44
41.6
15.3
%
14.1
13.6
4.66
183
1555
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
37
3.37
3.39
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
27
3.83
3.39
3.6
2.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
14
5.88
3.37
1.8
1.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
70
468
1.73
3.33
5.9
3.6
estimate
0.0
0.0
0.50
30
169
(40761535) Cells panel - Urine sediment
26
124
2.24
3.30
5.2
3.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
7
8.77
3.28
1.7
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
7
8.77
3.28
1.2
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
20
85
2.49
3.26
5.7
3.6
mmol/l
1.7
1.9
0.05
13
61
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
191
1681
2.00
3.18
30.0
11.4
ml/min/173m2
88.1
85.7
0.71
172
1379
(36660697) Celiac disease serology panel - Serum
31
162
2.06
3.14
1.2
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
8
16
5.14
3.08
1.1
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
16
5.14
3.08
2.5
2.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
16
5.14
3.08
5.4
1.2
umol/l
9.2
17.1
—
8
16
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
8
7.67
3.07
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
8
7.67
3.07
1.7
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
8
7.67
3.07
1.7
2.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
8
7.67
3.07
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
25
121
2.20
3.07
4.8
3.4
mmol/l
1.2
1.2
0.02
25
103
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
51
2.86
3.05
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
154
1280
1.67
3.04
3.8
3.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
12
5.98
3.04
2.4
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
46
703
0.56
3.01
2.3
2.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
5
10.19
2.99
1.0
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
5
10.19
2.99
1.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
5
10.19
2.99
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
5
10.19
2.99
1.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
5
10.19
2.99
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
93
686
1.61
2.98
5.5
3.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
83
596
1.63
2.96
3.9
3.3
mmol/l
2.3
2.4
4.84
76
522
(4027681)
7
13
5.52
2.89
1.7
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
9
6.81
2.88
1.0
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
9
6.81
2.88
1.3
1.4
ug/l
6.4
7.4
—
6
9
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
9
6.81
2.88
2.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
83
600
1.61
2.87
4.4
3.1
ng/l
28.4
37.1
0.34
60
367
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
104
2.24
2.86
1.5
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
78
2.42
2.83
11.7
14.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
18
4.57
2.82
1.3
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
23
4.03
2.80
1.9
1.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
23
4.03
2.80
3.7
3.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
6
8.49
2.76
2.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
120
2.12
2.73
2.4
2.6
ml/min/173m2
70.8
69.6
0.03
11
53
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
10
6.13
2.71
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
10
6.13
2.71
1.0
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
10
6.13
2.71
1.0
2.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
414
1.65
2.69
1.8
1.8
mg/l
1.0
1.0
0.08
46
314
(3044290) Cell count panel - Cerebral spinal fluid
11
38
2.99
2.62
1.7
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
15
4.78
2.62
9.1
1.6
pg
33.4
32.1
—
7
15
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
7
7.27
2.56
1.0
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.27
2.56
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
26
3.56
2.51
1.2
1.4
nmol/l
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
26
3.56
2.51
1.2
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
21
3.91
2.48
1.8
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
71
510
1.58
2.46
4.0
3.2
mmol/l
6.4
7.7
2.24
65
431
(3020682) Albumin/Creatinine [Ratio] in Urine
66
467
1.59
2.44
4.6
4.1
mg/mmol
5.8
12.5
1.16
46
283
(3017732) Neutrophils [#/volume] in Blood
24
126
2.01
2.42
3.0
2.7
e9/l
4.8
4.2
0.40
18
108
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
12
5.11
2.42
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
12
5.11
2.42
1.5
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
22
3.73
2.38
1.3
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
63
443
1.59
2.38
3.9
3.3
mg/l
30.5
218.8
0.66
43
271
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
8
6.36
2.38
2.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
8
6.36
2.38
2.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
18
3.98
2.27
1.1
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
9
5.65
2.22
2.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
9
5.65
2.22
2.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
9
5.65
2.22
3.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
162
1410
1.56
2.22
4.5
4.0
pmol/l
15.0
14.7
1.09
151
1290
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
24
3.42
2.20
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
191
0.40
2.18
1.5
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
14
4.37
2.16
1.2
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
14
4.37
2.16
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
37
2.78
2.13
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
10
5.09
2.08
1.6
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
10
5.09
2.08
1.0
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
156
1.83
2.08
3.8
3.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
63
2.30
2.05
1.4
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
147
1265
1.48
2.02
4.7
3.0
u/l
58.3
45.3
0.92
142
1198
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
143
1.84
1.99
1.6
1.2
iu/ml
20.7
146.3
—
10
57
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.62
1.95
1.8
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
11
4.62
1.95
1.4
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
11
4.62
1.95
1.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.62
1.95
1.8
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.62
1.95
1.8
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
11
4.62
1.95
1.8
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
39
2.64
1.95
1.3
1.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
16
3.82
1.95
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
91
721
1.45
1.90
2.1
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
46
2.46
1.88
1.7
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
59
2.28
1.88
1.6
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
318
1.56
1.85
5.0
3.2
ng/l
19.3
113.7
1.89
30
222
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
23
3.11
1.81
1.4
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
184
1675
1.59
1.80
5.6
4.7
mu/l
1.9
1.8
0.07
176
1548
(3027315) Oxygen [Partial pressure] in Blood
9
36
2.56
1.76
4.9
2.3
kpa
8.3
8.8
—
9
36
(3013290) Carbon dioxide [Partial pressure] in Blood
9
36
2.56
1.76
5.0
2.3
kpa
5.0
5.0
—
9
36
(3009542) Hematocrit [Volume Fraction] of Blood
186
1700
1.59
1.76
35.6
13.3
%
40.4
40.4
0.02
133
1298
(3021901) Oxygen saturation in Capillary blood
6
18
3.40
1.76
1.7
3.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
68
2.13
1.74
1.3
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
13
3.91
1.72
2.4
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
163
1778
0.68
1.64
4.0
4.2
mmol/l
4.4
4.7
3.05
158
1663
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
47
336
1.51
1.63
1.4
1.3
u/ml
14.9
11.0
0.10
18
134
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
162
1768
0.69
1.62
4.0
4.2
mmol/l
1.4
1.5
2.71
153
1650
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
14
3.63
1.62
1.4
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
43
302
1.53
1.61
2.4
2.9
mmol/l
2.4
2.4
1.54
36
257
(3045142) Bone marrow Pathology biopsy report
5
15
3.38
1.53
1.8
1.3
—
—
—
0
0
(4024509)
5
15
3.38
1.53
2.0
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
14
72
2.01
1.52
7.3
3.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
21
2.91
1.51
1.7
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
37
2.49
1.49
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
66
2.03
1.46
2.2
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
46
335
1.47
1.46
1.4
1.3
iu/ml
20.7
42.5
—
8
109
(3044889) 12 lead EKG panel
139
1222
1.37
1.45
4.6
3.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
16
3.17
1.44
1.8
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
22
2.77
1.44
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
206
0.51
1.38
1.2
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
134
0.43
1.33
1.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
18
2.82
1.29
1.6
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
157
1701
0.73
1.24
3.7
3.8
mmol/l
1.4
1.3
0.84
148
1581
(40761536) Microorganisms panel - Urine sediment
24
157
1.59
1.23
8.0
3.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
37
2.20
1.22
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
19
2.67
1.22
2.6
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
12
65
1.89
1.16
3.8
3.2
u/ml
7.9
2286.4
0.54
12
55
(4281824)
5
20
2.53
1.15
1.6
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
58
1.94
1.14
1.5
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
31
2.30
1.11
3.0
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
31
2.30
1.11
3.3
2.3
mmol/l
5.9
7.1
—
7
31
(3041096) Erythrocytes [Presence] in Urine by Automated
63
508
1.34
1.11
5.0
3.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
169
1802
0.74
1.09
4.6
4.6
mmol/l
2.6
2.8
1.54
157
1678
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
32
2.23
1.09
2.6
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
122
0.48
1.09
1.7
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
13
75
1.78
1.05
3.0
3.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
22
2.30
1.04
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
51
1.80
0.96
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
31
234
1.38
0.83
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
114
1.53
0.82
1.4
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
201
1934
1.43
0.78
28.4
11.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
30
230
1.35
0.74
1.6
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
27
1.87
0.69
2.0
4.3
—
—
—
0
0
(4306422)
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
21
155
1.39
0.66
11.6
4.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
71
1.58
0.63
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
80
1.53
0.61
2.3
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
125
1.39
0.55
2.2
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
62
1.47
0.54
1.2
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
227
1.27
0.49
1.8
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
191
1.29
0.49
14.9
6.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
49
1.44
0.46
1.3
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
122
1.34
0.43
1.3
1.3
—
43.8
—
0
7
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
47
410
1.19
0.43
1.5
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
33
1.53
0.41
1.6
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
33
1.53
0.41
1.6
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.8
—
16.6
—
0
15
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
152
1.27
0.38
2.6
2.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
36
1.40
0.38
2.4
1.9
umol/l
7.4
9.8
—
5
25
(1761482) Bacteria [#/volume] in Urine by Culture
6
43
1.41
0.35
3.2
3.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
57
519
1.13
0.31
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
38
339
1.15
0.28
1.4
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
1.0
—
0
13
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013512) EKG study
51
475
1.10
0.19
4.2
3.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
53
1.14
0.19
1.5
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
59
1.19
0.18
1.4
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
286
0.90
0.16
2.7
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
77
0.77
0.16
2.8
3.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
24
265
0.89
0.16
2.8
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
80
0.74
0.15
1.8
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
170
1730
0.92
0.15
4.7
4.1
mmol/l
5.9
5.8
0.46
162
1604
(1002224) Polysomnography panel
7
90
0.77
0.14
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
9
106
0.84
0.13
2.6
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
196
0.91
0.09
1.6
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
113
0.88
0.08
1.6
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
113
0.88
0.08
1.5
2.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
113
0.88
0.08
1.6
2.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
113
0.88
0.08
1.5
2.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
60
0.83
0.08
1.4
1.6
pmol/l
83.0
70.4
—
5
60
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
65
1.08
0.08
1.4
1.4
u/l
14.4
7.5
—
7
52
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
68
1.03
0.08
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
245
1.07
0.07
2.6
2.7
ug/l
0.6
0.7
0.80
19
137
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
85
1.06
0.07
1.3
2.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
162
1608
1.03
0.03
6.5
5.2
mmol/mol
39.8
39.0
0.37
153
1515
(3022621) pH of Urine by Test strip
12
113
1.07
0.02
3.6
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
323
1.03
0.01
3.3
3.9
%
22.4
21.7
0.10
17
128
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
104
1.06
0.01
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
103
0.97
0.00
1.4
2.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
8.4
—
0
9
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
1.2
—
0
8
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
16.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
2.0
—
0
7
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.0
—
1.2
—
0
6
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
9.4
—
0
7
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
78
0.89
0.00
1.6
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_CVID and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_CVID | 3.228 [2.32, 4.48] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.337 |
During the follow-up period (1.1.1998 — 31.12.2019), 106 out of 476 females with D3_CVID died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_CVID | 3.026 [2.02, 4.54] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 104 out of 347 males with D3_CVID died.
Mortality risk
Mortality risk for people of age
years, who have D3_CVID.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.287% | 0.681% |
| 5 | 2.034% | 3.255% |
| 10 | 5.02% | 7.718% |
| 15 | 8.881% | 14.648% |
| 20 | 15.33% | 23.297% |
Relationships between endpoints
↥Index endpoint: D3_CVID – Common variable immunodeficiency
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data